-
Mashup Score: 0
Click here to answer this week’s poll.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 3ASH Annual Meeting Abstracts - 3 year(s) ago
Abstracts submitted for oral and poster presentations at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 5,000 scientific abstracts are submitted each year and more than 3,000 abstracts are accepted for oral and poster presentations through an extensive peer review process. View the…
Source: www.hematology.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
👉👉👉Excited to present our group’s work on long-term outcomes & novel observations in our #BPDCN cohort at #ASH22 as oral presentation 🙌 | https://t.co/np3sqlsmX4 | Dec 11, 2022 | @ASH_hematology @doctorpemm @DrHKantarjian @mkonople | @MDAndersonNews | #endcancer https://t.co/EopXUgVRzk
-
-
Mashup Score: 1BPDCN: More Than Just a Rash - 3 year(s) ago
Blastic plasmacytoid dendritis cell neoplasm is a rare and aggressive form of cancer that usually makes its appearance in the form of red to violet papules and plaques.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Blastic plasmacytoid dendritic cell neoplasm(#BPDCN) is a rare and aggressive form of #cancer that usually makes its appearance in the form of red to violet papules and plaques. https://t.co/QYOQBptiPm
-
-
Mashup Score: 1ASH Annual Meeting Abstracts - 3 year(s) ago
Abstracts submitted for oral and poster presentations at the ASH annual meeting represent important, novel research in the field and are considered the best of the thousands of abstracts submitted. Typically, more than 5,000 scientific abstracts are submitted each year and more than 3,000 abstracts are accepted for oral and poster presentations through an extensive peer review process. View the…
Source: www.hematology.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
👉👉👉 #ASH22 abstracts are now live! 🩸 Looking forward to reviewing and discussing together ! Check them out at : https://t.co/np3sqlsmX4 | @ASH_hematology #leusm #MPNSM #bmtsm #mmsm #lymsm #BPDCN #RareDisease #ImmunoOnc 🙌 https://t.co/hPLLcAe0Ca
-
-
Mashup Score: 1Clinical Research Updates for Treating Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) - 3 year(s) ago
An expert weighs in on the latest updates in clinical research about this rare blood cancer that often manifests with cutaneous lesions.
Source: Dermatology TimesCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @FyfeWrites: Thanks for the great interview @doctorpemm! #BPDCN https://t.co/ZjUBt7VYAG
-
-
Mashup Score: 0Identification and Classification of BPDCN - 3 year(s) ago
Shared insight on methods to identify blastic plasmacytoid dendritic cell neoplasm followed by updated classifications from the World Health Organization.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Shared insight on methods to identify blastic plasmacytoid dendritic cell #neoplasm followed by updated classifications from the World Health Organization. #bpdcn | @doctorpemm @MDAndersonNews @HMHNewJersey @alegru18 @UVA_Pathology https://t.co/qXxSjopw7b
-
-
Mashup Score: 0
A world leader in BPDCN explains how using social media can enhance dermatologists’ knowledge about this rare form of aggressive blood cancer.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
A world leader in #BPDCN explains how using social media can enhance dermatologists’ knowledge about this rare form of aggressive #bloodcancer. https://t.co/e65gUEjmbG
-
-
Mashup Score: 0Clinical Research Updates for Treating Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) - 3 year(s) ago
An expert weighs in on the latest updates in clinical research about this rare blood cancer that often manifests with cutaneous lesions.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
An expert weighs in on the latest updates in clinical research about Blastic Plasmacytoid Dendritic Cell Neoplasm (#BPDCN) that often manifests with cutaneous lesions. https://t.co/D1dJwzeQb6
-
-
Mashup Score: 2Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New #podcast! We talk to Naveen Pemmaraju, MD, about the results of the largest prospective #BPDCN trial evaluating the CD123-targeted therapy tagraxofusp in adults with treatment-naive, R/R BPDCN: https://t.co/csgrt1PE8i Listen on Spotify: https://t.co/2wvfZKvBlY @doctorpemm https://t.co/tAOnHiTDFk
-
-
Mashup Score: 2Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New #podcast! We talk to Naveen Pemmaraju, MD, about the results of the largest prospective #BPDCN trial evaluating the CD123-targeted therapy tagraxofusp in adults with treatment-naive, R/R BPDCN: https://t.co/csgrt1y2JI Listen on Spotify: https://t.co/2wvfZKNcdw @doctorpemm https://t.co/Ed4ItsjSZA
-
Let us know: Have you ever treated blastic plasmacytoid dendritic cell neoplasm? #BPDCN https://t.co/moDMtLySfy